19236051|t|Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinase.
19236051|a|Amyloid-beta (Abeta) peptides, generated through sequential proteolytic cleavage of amyloid precursor protein (APP), aggregate to form amyloid plaques in Alzheimer's disease (AD). Understanding the regulation of Abeta generation and cellular secretion is critical to our understanding of AD pathophysiology. In the present study, we examined the role of the insulin/insulin-like growth factor-1 (IGF-1) signaling pathway in regulating APP trafficking and Abeta secretion. Previous studies have demonstrated that insulin or IGF-1 stimulation can increase Abeta and APP secretion in a phosphoinositide 3-kinase (PI3K) dependent manner. To expand upon these studies and better understand the molecular targets responsible for alterations in APP secretion, we constitutively activated Akt, a downstream component of the insulin/IGF-1 signaling pathway. Counterintuitively, constitutively active Akt (myr-Akt) overexpression produced an opposite effect to insulin/IGF-1 stimulation and inhibited secretion of APP and APP metabolites in multiple cell lines. Myr-Akt overexpression also resulted in increased APP protein stability. Since the insulin/IGF-1 signaling pathway is tightly regulated by feedback inhibition pathways, we hypothesized that myr-Akt overexpression may be inducing feedback inhibition of PI3K, resulting in impaired APP trafficking. In support of this hypothesis, myr-Akt acted at a known node of PI3K inhibition and decreased insulin receptor substrate 1 (IRS1) protein levels. Our studies provide further support for PI3K as a modulator of APP trafficking and demonstrate that overactivation of the insulin/IGF-1 signaling pathway may result in feedback inhibition of PI3K through IRS1 and reduce APP trafficking and Abeta secretion.
19236051	22	25	Akt	Gene	207
19236051	50	75	amyloid precursor protein	Gene	351
19236051	80	105	amyloid precursor protein	Gene	351
19236051	149	174	phosphoinositide 3-kinase	Gene	5293
19236051	176	188	Amyloid-beta	Gene	351
19236051	190	195	Abeta	Gene	351
19236051	260	285	amyloid precursor protein	Gene	351
19236051	311	326	amyloid plaques	Disease	MESH:D058225
19236051	330	349	Alzheimer's disease	Disease	MESH:D000544
19236051	351	353	AD	Disease	MESH:D000544
19236051	388	393	Abeta	Gene	351
19236051	464	466	AD	Disease	MESH:D000544
19236051	534	541	insulin	Gene	3630
19236051	542	570	insulin-like growth factor-1	Gene	3479
19236051	572	577	IGF-1	Gene	3479
19236051	631	636	Abeta	Gene	351
19236051	688	695	insulin	Gene	3630
19236051	699	704	IGF-1	Gene	3479
19236051	730	735	Abeta	Gene	351
19236051	759	784	phosphoinositide 3-kinase	Gene	5293
19236051	957	960	Akt	Gene	207
19236051	992	999	insulin	Gene	3630
19236051	1000	1005	IGF-1	Gene	3479
19236051	1067	1070	Akt	Gene	207
19236051	1076	1079	Akt	Gene	207
19236051	1127	1134	insulin	Gene	3630
19236051	1135	1140	IGF-1	Gene	3479
19236051	1232	1235	Akt	Gene	207
19236051	1311	1318	insulin	Gene	3630
19236051	1319	1324	IGF-1	Gene	3479
19236051	1422	1425	Akt	Gene	207
19236051	1560	1563	Akt	Gene	207
19236051	1619	1647	insulin receptor substrate 1	Gene	3667
19236051	1649	1653	IRS1	Gene	3667
19236051	1793	1800	insulin	Gene	3630
19236051	1801	1806	IGF-1	Gene	3479
19236051	1875	1879	IRS1	Gene	3667
19236051	1911	1916	Abeta	Gene	351
19236051	Positive_Correlation	207	3479
19236051	Association	207	3630
19236051	Positive_Correlation	MESH:D058225	351
19236051	Association	3630	3667
19236051	Positive_Correlation	351	3630
19236051	Association	3630	5293
19236051	Positive_Correlation	3479	351
19236051	Negative_Correlation	207	351
19236051	Association	207	5293
19236051	Negative_Correlation	207	3667
19236051	Association	MESH:D000544	351

